ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Circio (CRNA.OL)
Circio stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · Oslo Børs · Norway
NOK 11.54▲ +2.67%
Prices as of Oct 27, 2026 · NOK
Chance of rising in 1 month
45%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Circio in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Circio
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Circio a 45% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between NOK 9.71 and NOK 13.05; in 9 out of 10, between NOK 7.48 and NOK 16.95. Estimated annual volatility is 78%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- NOK 3.1B
- Market cap (USD)
- $335M
- 52-week high
- NOK 15.70
- 52-week low
- NOK 0.908
- Revenue (12 months)
- NOK 0.1M
- Operating margin
- 0.0%
- Net margin
- 0.0%
- Beta
- -1.03
What this means
ATLAS does not publish a fair value for CRNA.OL right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks CRNA.OL has traded between NOK 0.908 and NOK 15.70. Today it is 26.5% below that high and 1,171% above its low.
Its beta is -1.03: it tends to move less than the market.
About the company
Circio Holding ASA, a biotechnology company, develops novel circular RNA expression technology for gene and cell therapy.
Want to see everything about Circio?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Circio do?
Circio Holding ASA, a biotechnology company, develops novel circular RNA expression technology for gene and cell therapy.
What is the chance CRNA.OL goes up next month?
45%: close to a coin flip. In half of the simulated outcomes, CRNA.OL ends the month between NOK 9.71 and NOK 13.05.
How big is Circio and what is its P/E ratio?
Circio's market capitalization is NOK 3.1B. We do not show a P/E because it has no positive earnings to base one on.
How volatile is CRNA.OL?
ATLAS estimates annual volatility at 78%. In a typical month, half of the outcomes end between NOK 9.71 and NOK 13.05.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer